State Street's passive stake disclosure adds to a mixed institutional picture: Millennium Management increased to 7.4% (Oct 8 filing) while Vanguard and Principal Global Investors reduced below 5% (late Oct filings). Monitor for any future 13D conversion or further stake changes from State Street, though the passive certification makes activist intent unlikely.
COLL drugs
COLL drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $24.47entry
- T+1 · 6d ago +1.39%α +0.07% · $24.81
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
State Street Corp filed a Schedule 13G disclosing a 5.4% passive stake in Collegium Pharmaceutical as of September 30, 2026, holding 1,772,243 shares. This is a new 5%+ disclosure by a major custodian bank and asset manager, adding to a mixed pattern of recent institutional stake changes at Collegium.
Key Financial Metrics
Key Facts
- State Street Corp disclosed a 5.4% passive beneficial ownership stake in Collegium Pharmaceutical as of September 30, 2026
- State Street holds 1,772,243 shares of Collegium common stock
- The filing certifies passive intent under Rule 13d-1(b), with no intent to influence control
- This is a new 5%+ disclosure; State Street was not previously a reported 5% holder in the cross-filing context
- The filing comes 5 days after Collegium reported Q3 2026 earnings (revenue $216.3M, adjusted EPS $1.96 beating $1.86 consensus)
Financial Impact
State Street's 5.4% stake is valued at approximately $40.6M based on the $752M market cap
Risk Factors
- Passive 13G filing carries no activist intent, limiting near-term catalyst potential
- State Street is primarily a custodian/index fund manager; the stake may reflect passive fund flows rather than active conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000093751-26-000632 |
| Document: 0000093751-26-000632-index.html | 0000093751-26-000632 |
| Document: 0000093751-26-000632.txt | 0000093751-26-000632 |
Track record
24 reports on COLL
1 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +0.28% at T+1 after the Aug 13, 2026 report. 1 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $25.68 Now $25.43 −0.97% settles Nov 17
- Nov 10, 20266d ago SC 13G/A Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
- Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $24.47 to $24.81 Now $25.43 +3.92% ▲ +1.39% +0.07% vs SPY
- Nov 9, 20267d ago Institutional Cluster Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Neutral 5/10 Entry $25.16 to $24.21 Now $25.43 +1.07% ▼ −3.78% −4.09% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $23.80 to $23.68 Now $25.43 +6.85% ▼ −0.50% −0.03% vs SPY
- Oct 29, 202618d ago SC 13G/A Neutral 3/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
- Oct 29, 202618d ago Press Release Neutral 2/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $23.50 to $22.96 Now $25.43 +8.21% ▼ −2.30% −1.78% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers